
WAY Stock Forecast & Price Target
WAY Analyst Ratings
Bulls say
Waystar Holding Corp has demonstrated robust financial performance, exhibiting a compound annual growth rate (CAGR) of 16% in revenue since 2022, supported by strong subscription growth and a favorable market position, particularly in the ambulatory sector with 8% penetration. The company also experienced a notable 11.9% revenue growth driven by significant increases in both subscription (13.9%) and volume-based (9.7%) revenue streams, underscoring its competitive edge in healthcare technology. Additionally, the growth of high-value customers—now constituting approximately 4.15% of the total clientele with a quarterly growth rate of 3.4%—indicates strong demand for its enterprise-grade platform, further solidifying a positive outlook for Waystar Holding's stock.
Bears say
Waystar Holding Corp is facing several challenges that contribute to a negative outlook for its stock. The company's revenue is expected to decline sequentially in the third quarter, with fourth-quarter revenue projected to remain flat compared to the third quarter, reflecting a troubling trend in revenue generation. Additionally, a significant decrease in EBITDA—from 6.4x at the end of 2023 to 2.2x in 2Q—highlights declining profitability, which could be exacerbated by potential cybersecurity issues that threaten client relationships and overall growth potential.
This aggregate rating is based on analysts' research of Waystar Holding Corp and is not a guaranteed prediction by Public.com or investment advice.
WAY Analyst Forecast & Price Prediction
Start investing in WAY
Order type
Buy in
Order amount
Est. shares
0 shares